This model stratifies the population by disease progression, which could allow for the prioritization of patients with end stage liver disease or compensated cirrhosis for treatment now, while others with non-cirrhotic disease may be prioritized for treatment later. Contact an Express Scripts representative if you want to stratify by age as well.

Sources: Hepatitis Online. HCV Epidemiology in the United States. Page 2. Available at: Accessed June 13, 2014.

Gordon SC, Pockros PJ, Terrault NA, et al. Impact of disease severity on healthcare costs in patients with chronic hepatitis C (CHC) virus infection. Hepatology. Nov 2012;56(5):1651-1660.